Buckner, J C <br/><br/>
A phase III study of radiation therapy plus carmustine with or without recombinant interferon-alpha in the treatment of patients with newly diagnosed high-grade glioma.  [electronic resource] 

 -  Cancer  Jul 2001 
 - 420-33 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0008-543X 
<br/><br/><label>Standard No.: </label>10.1002/1097-0142(20010715)92:2<420::aid-cncr1338>3.0.co;2-3  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Agents--administration & dosage<br/>Antineoplastic Agents, Alkylating--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Brain Neoplasms--drug therapy<br/>Carmustine--administration & dosage<br/>Combined Modality Therapy<br/>Disease Progression<br/>Female<br/>Glioma--drug therapy<br/>Humans<br/>Interferon-alpha--administration & dosage<br/>Male<br/>Middle Aged<br/>Neoplasm Staging<br/>Survival Analysis<br/>Treatment Outcome